Jefferies Financial Group Inc. Eli Lilly & CO Put Options Transaction History

Jefferies Financial Group Inc.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $6.34 Million - $8.48 Million	-10,700 Reduced 96.4%	400 $311,000
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $735,266 - $866,782	-1,400 Reduced 11.2%	11,100 $6.47 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $10.1 Million - $13.9 Million	-23,200 Reduced 64.99%	12,500 $6.71 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $8.14 Million - $10.9 Million	23,200 Added 185.6%	35,700 $16.7 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $26.4 Million - $31 Million	-85,000 Reduced 87.18%	12,500 $4.29 Million
Q4 2022 Sep 21, 2023	BUY	$321.55 - $374.67 $19.9 Million - $23.2 Million	61,800 Added 173.11%	97,500 $35.7 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $31.4 Million - $36.5 Million	97,500 New	97,500 $35.7 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.